Re: 12 days and waiting
I donít think sharing the complete data at ESMO is a reason for holding off on the new phase 3 commencement. I also donít think it should have taken this long to work out with the FDA. So I wonder if something else is in the works? Could a possible EU approval be possible? If so, this would require a partner. If your going to partner for OUS, then maybe you can get them to fund some development costs for forward 2 or next gen folate etc.